CSPC Innovation Pharmaceutical Hits Day High with Strong 3.11% Intraday Surge

CSPC Innovation Pharmaceutical Co., Ltd. has experienced a notable increase of 3.11% on March 10, 2026, reaching an intraday high of CNY 32.39. This performance stands in contrast to the China Shanghai Composite, which rose by 0.65% on the same day. Over the past week, CSPC has shown a robust gain of 5.96%, while its one-month performance reflects a decline of 11.09%. Despite the recent uptick, CSPC's longer-term performance metrics reveal challenges. The company has faced a significant drop in net profit, with a staggering decline of 96.01% in the first half of the year. Additionally, the operating cash flow has reached a low of CNY -449.2 million, indicating financial strain. Over the past year, CSPC has underperformed the market, generating negative returns of 20.85%, while the broader index has seen gains of 21.47%. With a market capitalization of CNY 47,166 million, CSPC operates within the FMCG sector, but its financial indicators, including a return on equity of -15.39% and a high price-to-book ratio of 12.79, suggest a complex outlook for the company.